Hudson Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.11M | Buy |
88,864
+2,551
| +3% | +$118K | 1.17% | 41 |
|
|
2025
Q1 | $5.26M | Buy |
86,313
+4,182
| +5% | +$255K | 1.6% | 20 |
|
|
2024
Q4 | $4.65M | Sell |
82,131
-6,518
| -7% | -$369K | 1.44% | 31 |
|
|
2024
Q3 | $4.59M | Buy |
88,649
+1,042
| +1% | +$53.9K | 1.46% | 34 |
|
|
2024
Q2 | $3.64M | Buy |
87,607
+19,113
| +28% | +$794K | 1.22% | 41 |
|
|
2024
Q1 | $3.71M | Buy |
68,494
+6,641
| +11% | +$360K | 1.28% | 38 |
|
|
2023
Q4 | $3.17M | Buy |
61,853
+7,558
| +14% | +$388K | 1.15% | 44 |
|
|
2023
Q3 | $3.15M | Buy |
54,295
+8,798
| +19% | +$511K | 1.26% | 41 |
|
|
2023
Q2 | $2.91M | Buy |
45,497
+3,992
| +10% | +$255K | 1.12% | 45 |
|
|
2023
Q1 | $2.88M | Buy |
41,505
+4,096
| +11% | +$284K | 1.14% | 41 |
|
|
2022
Q4 | $2.69M | Buy |
37,409
+2,261
| +6% | +$163K | 1.07% | 41 |
|
|
2022
Q3 | $2.5M | Buy |
+35,148
| New | +$2.5M | 1.24% | 23 |
|